Cetera Investment Advisers Autolus Therapeutics PLC Transaction History

Cetera Investment Advisers

$49.2 Billion
Q1 2025

A detailed history of Cetera Investment Advisers transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Cetera Investment Advisers holds 524,872 shares of AUTL stock, worth $1.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

524,872

Previous 356,222 47.34%

Holding current value

$1.26 Million

Previous $837,000 2.87%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 06, 2025	BUY	$1.55 - $2.68 $261,407 - $451,982	168,650 Added 47.34%	524,872 $813,000
Q4 2024 Feb 13, 2025	BUY	$2.18 - $4.8 $488,803 - $1.08 Million	224,222 Added 169.87%	356,222 $837,000
Q3 2024 Nov 13, 2024	SELL	$3.38 - $4.69 $8,450 - $11,725	-2,500 Reduced 1.86%	132,000 $479,000
Q2 2024 Aug 22, 2024	BUY	$3.33 - $5.68 $9,054 - $15,443	2,719 Added 2.06%	134,500 $468,000
Q1 2024 May 24, 2024	BUY	$5.39 - $7.29 $710,299 - $960,683	131,781 New	131,781 $840,000
Q4 2023 Feb 13, 2024	SELL	$2.13 - $6.63 $5,325 - $16,575	-2,500 Reduced 1.87%	131,500 $846,000
Q3 2023 Nov 14, 2023	SELL	$2.32 - $3.36 $2,784 - $4,032	-1,200 Reduced 0.89%	134,000 $312,000
Q2 2023 Aug 09, 2023	SELL	$1.64 - $3.21 $10,496 - $20,544	-6,400 Reduced 4.52%	135,200 $321,000
Q1 2023 May 15, 2023	BUY	$1.75 - $2.25 $7,000 - $9,000	4,000 Added 2.91%	141,600 $260,000
Q4 2022 Feb 14, 2023	BUY	$1.74 - $3.27 $3,828 - $7,194	2,200 Added 1.62%	137,600 $261,000
Q3 2022 Nov 10, 2022	BUY	$2.04 - $3.76 $17,136 - $31,584	8,400 Added 6.61%	135,400 $290,000
Q2 2022 Aug 11, 2022	BUY	$2.04 - $4.68 $5,508 - $12,636	2,700 Added 2.17%	127,000 $359,000
Q1 2022 May 13, 2022	BUY	$3.52 - $5.46 $33,616 - $52,143	9,550 Added 8.32%	124,300 $518,000
Q4 2021 Feb 14, 2022	BUY	$5.1 - $7.0 $49,215 - $67,550	9,650 Added 9.18%	114,750 $596,000
Q3 2021 Nov 16, 2021	BUY	$5.32 - $7.37 $559,132 - $774,587	105,100 New	105,100 $688,000

Others Institutions Holding AUTL

# of Institutions

Shares Held

163M

Call Options Held

Put Options Held

88.3K

View Full List

About Autolus Therapeutics plc

Ticker AUTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,909,800
Market Cap $218M
Description
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...

More about AUTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.

Account

Cetera Investment Advisers Autolus Therapeutics PLC Transaction History